Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Comparison of Nickel Sulfate 2.5% and Nickel Sulfate 5% for Detecting Nickel Contact Allergy

Goldminz, Ari M., MD; Scheinman, Pamela L., MD

doi: 10.1097/DER.0000000000000419
STUDIES

Background Nickel is among the most common contact allergens found on patch testing worldwide and, because of its ubiquitous nature in our environment, often has important implications for allergen avoidance strategies. In both North America and Europe, nickel positivity is found in approximately 20% of patients who undergo patch testing. Whereas in North America, nickel sulfate is typically tested at a concentration of 2.5%, in Europe, it is tested at a 5% concentration.

Objective The primary objective was to assess the differences in patch test positivity to nickel sulfate 2.5% and 5%.

Methods We investigated 205 consecutive patients between September 2017 and February 2018 who were tested to nickel sulfate at concentrations of both 2.5% and 5%.

Results Among the 205 patients tested, 33% were positive (+, ++, or +++) to at least 1 concentration of nickel sulfate, 20% were positive to nickel sulfate 2.5%, and 31% were positive to nickel sulfate 5% (χ2 1(N = 205) = 16.1, P = 0.0001). Patients were 6.5 times more likely to have a positive reaction to nickel sulfate 5% than 2.5% (odds ratio 95% confidence interval, 2.3–25.6).

Conclusions Given our findings, we propose an additional evaluation of nickel sulfate 5% as a standard allergen for patch testing in North America.

From the Department of Dermatology, Brigham and Women's Hospital, Chestnut Hill, MA.

Address reprint requests to Ari M. Goldminz, MD, Department of Dermatology, Brigham and Women's Hospital, 850 Boylston St, Suite 437, Chestnut Hill, MA 02467. E-mail: agoldminz@bwh.harvard.edu.

A.M.G.'s wife owns stock in Johnson and Johnson. P.L.S. is a consultant for Squire Patton Boggs law firm, a lecturer for Brigham and Women's Hospital Allergy Department, and an author for UptoDate.

© 2018 American Contact Dermatitis Society
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website